Form 4: Cryoport Director Hancock Receives Stock Options and Restricted Stock Rights

Director Daniel M. Hancock of Cryoport, Inc. reports acquisition of stock options and restricted stock rights.

Summary

• On May 17, 2024, Daniel M. Hancock, a director of Cryoport, Inc., reported transactions involving the company's securities.
• Hancock acquired 12,845 shares of common stock at $0 and disposed of 35,488 shares.
• He also acquired options to purchase 23,830 shares of common stock at an exercise price of $12.65, exercisable starting June 17, 2024, and expiring on May 17, 2031.
• The restricted stock rights vest in full on May 17, 2025, and convert to common stock on a one-for-one basis.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to stock options and restricted stock rights granted to a director. It doesn't inherently indicate positive or negative performance.

Positives

• The grant of stock options and restricted stock rights to a director aligns their interests with those of the shareholders.
• The vesting schedule for the options (1/12th per month starting June 17, 2024) encourages continued service and contribution to the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• Shareholders can monitor insider transactions to assess management's alignment with their interests.

Key Dates